文献速递口腔黏膜病口腔颌面外科

基于多维人工智能的口腔白斑癌变进展预测模型

Multidimensional Artificial Intelligence-Based Cancer Progression Prediction in Oral Leukoplakia.
PubMed 文献 · J Dent Res · 2025-10-18

本研究开发了整合患者特征、组织学特征和免疫组化指标的时间-事件人工智能模型OralCancerPredict,用于精准预测口腔白斑的癌变进展。回顾性分析456例患者和1312份组织样本,外部验证119例患者和322份样本,模型在测试和外部验证中一致性指数为0.855~0.867,曲线下面积为0.877~0.882,综合Brier评分为0.046~0.069,且净获益优于WHO和二元异型增生分级系统。

要点

  • OralCancerPredict整合临床、病理和KRT13/p53免疫组化数据预测口腔白斑癌变风险。
  • 模型在测试和外部验证中表现出良好区分度、校准度和净获益。
  • KRT13和p53表达失调及WHO异型增生分级对预测至关重要。

核心结论

  • OralCancerPredict能预测口腔白斑患者的癌变风险和癌变无进展生存,具有良好的区分度、校准度和净获益。

研究设计与样本

  • 回顾性分析患者数据(n=456)和组织样本(n=1,312),用于模型训练和测试。
  • 外部验证基于未用于训练和测试的患者数据(n=119)和组织样本(n=322)。

主要发现

  • 测试和外部验证中一致性指数为0.855~0.867,曲线下面积为0.877~0.882,综合Brier评分为0.046~0.069。
  • 可解释性分析确认KRT13和p53表达失调及WHO异型增生分级对预测癌变风险和癌变无进展生存的重要性。
  • 模型净获益优于单独使用WHO和二元异型增生分级系统。

临床怎么用

  • 该可解释人工智能模型有望简化口腔白斑临床管理中的干预和密切监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Oral cancer often develops from oral potentially malignant disorders. Oral leukoplakia (OL) is the most common oral potentially malignant disorder. However, not all patients with OL develop oral cancer in their lifetimes, and cancer risk assessment is challenging. This study developed a time-to-event artificial intelligence-based model (termed OralCancerPredict) that integrated patient characteristics, histologic features, and immunohistochemical indicators for precise prediction of cancer progression in OL. We performed a retrospective analysis of patient data (n = 456) and tissue samples (n = 1,312) obtained before cancer progression or at last follow-up for patients with OL. KRT13 and p53 immunohistochemistry and quantitative analyses were performed for tissue samples, while independent prognostic features, including demographic characteristics, clinical information, and histopathologic findings, were obtained for patients in the cohort. KRT13 and p53 expression was combined with histologic and patient data for model training, testing, and external validation. Performance evaluation for OralCancerPredict included model discriminative ability, calibration, explainability, and net benefit analysis via decision curves. External validation was also performed to ensure model generalizability based on patient data (n = 119) and tissue samples (n = 322) unused for training and testing. Our findings showed that OralCancerPredict trained on multidimensional data had good concordance indices (0.855 to 0.867), areas under the curve (0.877 to 0.882), and integrated Brier scores (0.046 to 0.069) at testing and external validation. Explainability analysis confirmed the importance of KRT13 and p53 deregulated expression and World Health Organization dysplasia grading to OralCancerPredict in predicting the risk of cancerization and cancer progression-free survival. Moreover, the model had a better net benefit than the World Health Organization and binary dysplasia grading systems alone, which represent the current risk stratification methods in OL management. Overall, OralCancerPredict can predict the risk of cancer development and cancer progression-free survival for patients with OL, with good discrimination, calibration, and net benefit. The explainable artificial intelligence model has the potential to streamline intervention and close monitoring in the clinical management of OL.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Adeoye J, Wang H, Lo AWI, et al. Multidimensional Artificial Intelligence-Based Cancer Progression Prediction in Oral Leukoplakia. J Dent Res. 2025. PMID: 41108137. doi:10.1177/00220345251378053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。